Zealand Pharma Feed

Land	Danmark
Lista	Large Cap Copenhagen
Sektor	Hälsovård
Industri	Bioteknik

2022-10-04 22:07:25 Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 million -4,19% | 117 MDKK

2022-10-04 17:05:59 Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares -4,19% | 117 MDKK

2022-09-30 22:00:00 Total number of shares and voting rights in Zealand Pharma at September 30, 2022 -3,62% | 102 MDKK

2022-09-30 12:15:00 Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1) +28,46% | 233 MDKK

2022-09-21 14:15:00 Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD) +2,88% | 16,7 MDKK

2022-09-19 08:00:00 Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE Meeting -6,70% | 15,8 MDKK

2022-09-13 22:05:00 Zealand Pharma grants warrants to employees in Denmark -0,07% | 17,5 MDKK

2022-09-08 22:05:00 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants +6,84% | 60,5 MDKK

2022-09-07 17:00:00 Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference +3,82% | 24,9 MDKK

2022-09-07 08:00:00 Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon) +2,97% | 77,7 MDKK

2022-08-31 21:30:00 Total number of shares and voting rights in Zealand Pharma at August 31, 2022 -7,34% | 19,4 MDKK

2022-08-24 10:30:00 Zealand Pharma Appoints Henriette Wennicke as Chief Financial Officer +7,21% | 35,7 MDKK

2022-08-18 20:58:45 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants -0,49% | 20,4 MDKK

2022-08-11 15:00:00 Zealand Pharma Announces Financial Results for the First Half of 2022 +7,92% | 33,5 MDKK

2022-08-08 22:30:00 Updated notice to holders of ADSs regarding termination of Deposit Agreement -3,39% | 21,4 MDKK

2022-08-08 22:05:00 Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select Market -3,39% | 21,4 MDKK

2022-08-04 15:00:00 Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022 -3,01% | 31,0 MDKK

2022-06-30 15:44:22 Total number of shares and voting rights in Zealand Pharma at June 30, 2022 -2,06% | 10,3 MDKK

2022-06-15 22:00:00 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities -4,23% | 14,9 MDKK

2022-06-10 19:00:00 Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022 -3,09% | 19,7 MDKK

2022-06-07 00:30:00 Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual American Diabetes Association Scientific Sessions and Announces Dapiglutide to Move into Phase 2 Trial for Obesity +1,05% | 22,7 MDKK

2022-06-03 15:18:51 Zealand Pharma completes registration of capital increase +0,89% | 16,3 MDKK

2022-06-03 14:30:00 Zealand Pharma to Participate in Upcoming Investor Conferences +0,89% | 16,3 MDKK

2022-06-02 08:00:00 Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Officer -3,33% | 30,1 MDKK

2022-06-01 17:30:00 Zealand Pharma announces directed issue and private placement corresponding to approx. 6.6 % of existing share capital -3,33% | 30,1 MDKK

2022-05-31 22:08:36 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities -5,67% | 29,1 MDKK

2022-05-31 13:00:00 Zealand Pharma Announces Multiple Presentations at the 82nd Annual American Diabetes Association Scientific Sessions, Including Initial Clinical Data on GLP-1/GLP-2 Dual Agonist Dapiglutide -2,18% | 23,0 MDKK

2022-05-25 22:30:24 Zealand Pharma launches long-term incentive program for Zealand’s Corporate Management and employees for 2022 +9,08% | 32,0 MDKK

2022-05-25 22:27:28 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities +9,08% | 32,0 MDKK

2022-05-19 13:35:00 Zealand Pharma Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pediatric Patients with Congenital Hyperinsulinism (CHI) +15,04% | 91,3 MDKK

2022-05-17 12:04:00 Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device +13,62% | 39,0 MDKK

2022-05-12 22:05:00 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities [CORRECTED] -2,44% | 29,4 MDKK

2022-05-12 18:05:00 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities -2,44% | 29,4 MDKK

2022-05-12 15:00:00 Zealand Pharma Provides Update on Refocused Strategy Prioritizing Research and Development -5,75% | 23,5 MDKK

2022-05-10 22:05:00 Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022 +1,16% | 13,0 MDKK

2022-05-10 03:17:33 Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company’s Refocused Strategy +1,51% | 16,6 MDKK

2022-05-05 10:00:00 Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Quarter Results for 2022 +0,95% | 19,5 MDKK

2022-04-22 17:00:00 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities -2,80% | 17,6 MDKK

2022-04-20 22:30:00 Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors for 2022 +1,27% | 17,8 MDKK

2022-04-07 16:18:21 Correction: Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 2022 -4,49% | 21,1 MDKK

2022-04-07 09:00:00 Zealand Pharma major shareholder announcement: The Capital Group Companies, April 7 2022 -4,49% | 21,1 MDKK

2022-04-06 16:42:51 Zealand Pharma's Annual General Meeting 2022 -3,96% | 19,3 MDKK

2022-04-04 14:30:00 Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference +2,85% | 28,0 MDKK

2022-03-30 15:15:00 Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize Research & Development and Streamlines Operations +11,04% | 77,7 MDKK

2022-03-11 17:08:18 Correction: Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022. +6,37% | 48,4 MDKK

2022-03-10 15:01:00 Zealand Pharma convenes its Annual General Meeting 2022 +1,11% | 29,8 MDKK

2022-03-10 15:00:00 Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022. +1,11% | 29,8 MDKK

2022-03-03 10:00:00 Zealand Pharma Hosts Conference Call on March 10 at 4 pm CET (10am ET) to Present Full Year Results for 2021 -3,66% | 21,8 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2022-11-10	Kvartalsrapport 2022-Q3
2022-08-11	Kvartalsrapport 2022-Q2
2022-05-12	Kvartalsrapport 2022-Q1
2022-05-09	Ordinarie utdelning ZEAL 0.00 DKK
2022-04-06	Årsstämma 2022
2022-03-10	Bokslutskommuniké 2021
2021-11-11	Kvartalsrapport 2021-Q3
2021-08-12	Kvartalsrapport 2021-Q2
2021-05-12	Kvartalsrapport 2021-Q1
2021-04-16	Ordinarie utdelning ZEAL 0.00 DKK
2021-04-15	Årsstämma 2021
2021-03-11	Bokslutskommuniké 2020
2020-11-12	Kvartalsrapport 2020-Q3
2020-08-13	Kvartalsrapport 2020-Q2
2020-05-14	Kvartalsrapport 2020-Q1
2020-04-03	Ordinarie utdelning ZEAL 0.00 DKK
2020-04-02	Årsstämma 2020
2020-03-12	Bokslutskommuniké 2019
2019-11-14	Kvartalsrapport 2019-Q3
2019-08-15	Kvartalsrapport 2019-Q2
2019-05-16	Kvartalsrapport 2019-Q1
2019-04-05	Ordinarie utdelning ZEAL 0.00 DKK
2019-04-04	Årsstämma 2019
2019-03-07	Bokslutskommuniké 2018
2018-11-15	Kvartalsrapport 2018-Q3
2018-08-16	Kvartalsrapport 2018-Q2
2018-05-16	Kvartalsrapport 2018-Q1
2018-04-20	Ordinarie utdelning ZEAL 0.00 DKK
2018-04-19	Årsstämma 2018
2018-03-07	Bokslutskommuniké 2017
2017-11-08	Kvartalsrapport 2017-Q3
2017-08-24	Kvartalsrapport 2017-Q2
2017-05-17	Kvartalsrapport 2017-Q1
2017-04-06	Ordinarie utdelning ZEAL 0.00 DKK
2017-04-05	Årsstämma 2017
2017-03-15	Bokslutskommuniké 2016
2016-11-09	Kvartalsrapport 2016-Q3
2016-08-25	Kvartalsrapport 2016-Q2
2016-05-18	Kvartalsrapport 2016-Q1
2016-04-20	Ordinarie utdelning ZEAL 0.00 DKK
2016-04-19	Årsstämma 2016
2016-03-16	Bokslutskommuniké 2015
2015-11-05	Kvartalsrapport 2015-Q3
2015-08-28	Kvartalsrapport 2015-Q2
2015-05-22	Kvartalsrapport 2015-Q1
2015-04-22	Ordinarie utdelning ZEAL 0.00 DKK
2015-04-21	Årsstämma 2015
2015-03-12	Bokslutskommuniké 2014
2014-03-21	Ordinarie utdelning ZEAL 0.00 DKK
2013-04-30	Ordinarie utdelning ZEAL 0.00 DKK
2012-04-26	Ordinarie utdelning ZEAL 0.00 DKK
2012-04-25	Årsstämma 2012
2011-04-29	Ordinarie utdelning

Zealand Pharma

Beskrivning

Kalender

Zealand Pharma

Beskrivning

Kalender

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden